Shabbir Mostafa, global key account director for Recipharm Inhalation Solutions, looks at the techniques to reduce time to market during inhalation drug development and manufacturing.
Getting drugs with unstable characteristics to the patient is a complicated process. One company believes it may have the solution, as Sylvie Ponlot from Technoflex explains.
EPM editor Reece Armstrong caught up with Frederique Bordes-Picard, business development for innovative products capsule delivery solutions at Lonza to learn more about the company's new dry-powder inhalation capsule.
Pascale Farjas, global category manager for drug delivery company Nemera examines the design features that help improve adherence for patients using nasal spray devices.
Sven Stegemann, director of pharmaceutical business development, Lonza Pharma & Biotech, discusses how using sprinkle formulation technology helps manufacturers focus on the patient in medicine development.
Data and analytics company, GlobalData, has revealed that it believes new launches into the epinephrine injection device market will have the potential to completely transform the space.
The recent collaboration between Merck and InnoCore Pharmaceuticals for the development of a new drug delivery platform that will improve compliance could be a step forward in the delivery of biologics, according to GlobalData
In this article, Dr Malcolm Haddrick (Medicines Discovery Catapult) and Professor Steve Evans (University of Leeds) highlight the exciting and innovative new method of drug delivery — microbubbles.
